Quantessence Capital’s MetLife MET Stock Holding History

Quantessence Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,082	Closed	-$662K	–	422
2024 Q4	$662K	Buy	+8,082	New	+$673K	0.27%	87

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quantessence Capital's MET Position: Q1 2025 in Review

Quantessence Capital sold out of MetLife (MET) in Q1 2025, closing a stake of 8,082 shares — an estimated $662K sold.

Quantessence Capital first reported a position in MET in Q4 2024 and held it in 1 quarter. The position peaked at $662K in Q4 2024. 1,407 funds tracked by Wall St. Rank hold MET as of Q1 2025.

Quantessence Capital reported no remaining MetLife position as of Q1 2025 after selling out during the quarter.
Quantessence Capital sold 8,082 MetLife shares in Q1 2025, an estimated $662K.
Quantessence Capital first reported a position in MetLife in Q4 2024 and held it in 1 quarter.
Quantessence Capital's MetLife position peaked at $662K in Q4 2024.
1,407 funds tracked by Wall St. Rank held MetLife as of Q1 2025.

Based on Quantessence Capital's 13F filing for Q1 2025, filed 15 May 2025.